ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CHFS CHF Solutions Inc

5.28
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
CHF Solutions Inc NASDAQ:CHFS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 5.28 5.10 5.32 0 01:00:00

CHF Solutions, Inc. to Present at the Ladenburg Thalmann’s 2019 Healthcare Conference on September 24, 2019

19/09/2019 1:00pm

GlobeNewswire Inc.


CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more CHF Solutions Charts.

CHF Solutions, Inc. (Nasdaq:CHFS) today announced that Claudia Napal Drayton, the company’s CFO, will be presenting and meeting with investors at the 2019 Landenburg Thalmann’s 2019 Healthcare Conference on September 24, 2019 at 4:00 PM ET in Track 6 of the Madeleine Room.  The conference will be held September 24-25 at the Sofitel in New York City.

For those interested in attending the conference or arranging a one-on-one meeting with management, please contact conference organizers at HealthcareConference@Ladenburg.com or Bret Shapiro of CORE IR at 516-222-2650 or at brets@coreir.com.

About CHF SolutionsCHF Solutions, Inc. (Nasdaq:CHFS) is a medical device company focused on developing, manufacturing and commercializing the Aquadex FlexFlow® system for aquapheresis therapy. The Aquadex FlexFlow system is a clinically proven therapy that provides a safe, effective, and predictable method of removing excess sodium and fluid from patients suffering from fluid overload. The Aquadex FlexFlow system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company is dedicated to changing the lives of patients suffering from fluid overload through science, collaboration, and innovative. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the Nasdaq Capital Market since February 2012.

CONTACTS:

INVESTORS: Claudia Napal Drayton Chief Financial Officer CHF Solutions, Inc. 952-345-4205 ir@chf-solutions.com-or- Bret Shapiro Managing Partner CORE IR 516-222-2560 brets@coreir.com www.coreir.comMEDIA Jules Abraham JQA Partners, Inc. 917-885-7378 jabraham@jqapartners.com

1 Year CHF Solutions Chart

1 Year CHF Solutions Chart

1 Month CHF Solutions Chart

1 Month CHF Solutions Chart

Your Recent History

Delayed Upgrade Clock